Gland Pharma

Divi's Labs, Laurus Labs, Sai Life Sciences and Glenmark Pharma quoted at their respective record highs in Monday's trade.

Updated On: 09 Nov 2026 | 12:23 PM IST

Gland Pharma on Friday posted a 58.29 per cent rise in consolidated net profit to Rs 290.75 crore in the September quarter, driven by strong execution across businesses. The company had reported a net profit of Rs 183.68 crore in the year-ago period. The pharmaceutical company's revenue from operations rose to Rs 1,833.58 crore in the quarter under review from Rs 1,486.87 crore a year ago, the company said in a regulatory filing. Total expenses also rose to Rs 1,471.69 crore in the July-September period from Rs 1,287.12 crore a year earlier, it said. The company launched four molecules -- Sugammadex, Erythromycin, Fluorouracil and Atropine sulfate -- in the US this quarter, it said in a release. Gland Pharma Executive Chairman Srinivas Sadu said, "We delivered another quarter of strong growth...driven by strong execution across our businesses. Our CDMO business grew 31 per cent year-on-year, supported by expanding customer engagements, strategic partnerships and a robust opportuni

Updated On: 06 Nov 2026 | 8:17 PM IST

Hindalco Industries, Honasa Consumer, Siemens, Aster DM Quality Care, Blue Dart Express, Bombay Dyeing & Manufacturing Company are among the companies to report Q2FY27 results.

Updated On: 06 Nov 2026 | 8:05 AM IST

India's CRDMO sector growth rebounded to 19% YoY in Q1FY27 versus just 9% YoY in the March 2026 quarter, marking the highest growth level since the December 2024 quarter, notes Jefferies.

Updated On: 26 Aug 2026 | 11:22 AM IST

Gland Pharma Share: The market price of Gland Pharma hit a high of ₹2,989.2 in intra-day deals on Tuesday. The stock bounced back 90 per cent from its 52-week low of ₹1,575 touched on March 16, 2026.

Updated On: 11 Aug 2026 | 11:06 AM IST

In the past six months, the stock price of Neuland Labs outperformed the market by surging 68 per cent, as compared to 6 per cent decline in the BSE Sensex.

Updated On: 06 Aug 2026 | 10:38 AM IST

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Updated On: 22 Jul 2026 | 10:19 AM IST

Sentiment was further buoyed by bullish brokerage commentary, with Elara Capital and Motilal Oswal Financial Services retaining Buy calls on Gland Pharma, citing strong earnings

Updated On: 18 May 2026 | 12:36 PM IST

Gland Pharma jumped 4.80 per cent to ₹1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.

Updated On: 08 Jan 2026 | 11:05 AM IST

Stocks to Watch today, January 8, 2026: From Tata Steel to Cipla, here is a list of stocks that will be on investors' radar

Updated On: 08 Jan 2026 | 8:05 AM IST

Stocks to Watch today, November 4, 2025: From Bharti Airtel, Hero MotoCorp, Titan Company, and Power Grid, here is a list of stocks that will be in focus today

Updated On: 04 Nov 2025 | 8:18 AM IST

The consolidated net profit rose to 1.84 billion rupees (nearly $21 million) for the quarter ended September 30 from 1.64 billion rupees a year earlier

Updated On: 03 Nov 2025 | 5:28 PM IST

Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details

Updated On: 25 Aug 2025 | 12:22 PM IST

The pharma company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹215 crore, up 50 per cent from ₹143 crore reported in the corresponding quarter of the previous fiscal year.

Updated On: 06 Aug 2025 | 11:47 AM IST

Sequentially, the company's net profit rose by 15 per cent, and revenue increased by 6 per cent

Updated On: 05 Aug 2025 | 11:20 PM IST

The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.

Updated On: 22 Jul 2025 | 11:43 AM IST

Gland Pharma shares rose 2 per cent after it received a GMP certification from the Danish Medicines Agency for its Telangana plant

Updated On: 14 Jul 2025 | 10:29 AM IST

Donald Trump threatens of a potential 200% tariff on pharma imports; can this derail the rally in pharma shares, which have gained up to 50% in 3 months. Here's what the technical charts suggest.

Updated On: 09 Jul 2025 | 10:34 AM IST

Gland Pharma share price rose 3 per cent logging an intraday high at ₹1,800 per share; here's why

Updated On: 24 Jun 2025 | 12:29 PM IST

The Nifty Pharma index and select shares such as Biocon, Cipla, Zydus Life and Gland Pharma were trading above the respective 200-DMAs after more than 2 months; show technical charts.

Updated On: 12 Jun 2025 | 1:05 PM IST